Tailoring Radiotherapies and Nanotechnology for Targeted Treatment of Solid Tumors

Muhammad Imran Khan,Fakhra Batool,Rizwan Ali,Qurat ul ain Zahra,Wenshen Wang,Shibo Li,Gangguo Wang,Liangliang Liu,Safir Ullah Khan,Majad Mansoor,Muhammad Bilal,Weiping Ding,Ahsan Kazmi,Fenfen Li,Bensheng Qiu

DOI: https://doi.org/10.1016/j.ccr.2022.214757

IF: 24.833

2022-01-01

Coordination Chemistry Reviews

Abstract:Existing anticancer therapeutic modalities in clinical settings lack efficacy and fail to completely cure cancers. Clearly understandable and mechanistic approaches are inevitable to improve the efficiency of anticancer therapies. There is indestructible evidence that radioactive materials have been used in cancer therapies since 1890, but toxicities restrict their broad clinical utility. Preliminary studies explain a deeper understanding of radioactive material properties and its interaction with living organisms. Advanced characterization advocates discriminatory responses of radioactive materials to various materials invitro and in vivo models. This indicates that repurposing therapeutic strategies is indispensable. Contemporary innovative and integrated scientific environment has provided opportunity to forward attractive platforms for cancer radiotherapies. In recent years, the emerging concept of integration of nanotechnology and radiotherapies has energized the therapeutic outcomes in various preclinical models. Resurfacing the idea of transforming external radiotherapies into internal radiotherapies has become an interesting research area in cancer therapeutics. Initial evaluations indicate that stipulating nanoparticles with alpha emitters can show a landscaping route for their targeted anticancer activities. However, the interaction of various elements such as radionuclides with their carrier results in modified physical and chemical characteristics, which mandates the careful evaluation and selection of materials. Besides, dosimetry is also an important concern for radiotherapies due to its off-target toxicities and half-life radioactive elements. In view of these facts and recent updates on radiotherapies, this review provides a comprehensive and comparative overview of various types of radiotherapies and rationally compares their efficacy, advantages and disadvantages, and discusses various types of biomaterials and their perspective in radiotherapies. Further, this manuscript through light on assimilated approaches to reengineering radiotherapies. Also, it explores and discusses the narrative on targeted alpha radiotherapy and provides a comparison with other forms of radiotherapies. In general, this manuscript discusses the nanotechnology perspective of radiotherapies.